Your browser doesn't support javascript.
loading
A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation.
Murphy, Sean C; Duke, Elizabeth R; Shipman, Kelly J; Jensen, Ryan L; Fong, Youyi; Ferguson, Sue; Janes, Holly E; Gillespie, Kevin; Seilie, Annette M; Hanron, Amelia E; Rinn, Laurie; Fishbaugher, Matthew; VonGoedert, Tracie; Fritzen, Emma; Kappe, Stefan H; Chang, Ming; Sousa, Jason C; Marcsisin, Sean R; Chalon, Stephan; Duparc, Stephan; Kerr, Nicola; Möhrle, Jörg J; Andenmatten, Nicole; Rueckle, Thomas; Kublin, James G.
Afiliação
  • Murphy SC; Department of Laboratory Medicine, University of Washington, Seattle, Washington.
  • Duke ER; Department of Microbiology, University of Washington, Seattle, Washington.
  • Shipman KJ; Center for Emerging and Re-emerging Infectious Diseases, Seattle, Washington.
  • Jensen RL; Seattle Malaria Clinical Trials Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Fong Y; Human Challenge Center, Center for Infectious Disease Research, Seattle, Washington.
  • Ferguson S; Department of Medicine, University of Washington, Seattle, Washington.
  • Janes HE; Seattle Malaria Clinical Trials Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Gillespie K; Seattle Malaria Clinical Trials Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Seilie AM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Hanron AE; Seattle Malaria Clinical Trials Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Rinn L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Fishbaugher M; Seattle Malaria Clinical Trials Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • VonGoedert T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Fritzen E; Seattle Malaria Clinical Trials Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Kappe SH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Chang M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Sousa JC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Marcsisin SR; Department of Laboratory Medicine, University of Washington, Seattle, Washington.
  • Chalon S; Department of Laboratory Medicine, University of Washington, Seattle, Washington.
  • Duparc S; Seattle Malaria Clinical Trials Center, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Kerr N; Human Challenge Center, Center for Infectious Disease Research, Seattle, Washington.
  • Möhrle JJ; Human Challenge Center, Center for Infectious Disease Research, Seattle, Washington.
  • Andenmatten N; Human Challenge Center, Center for Infectious Disease Research, Seattle, Washington.
  • Rueckle T; Human Challenge Center, Center for Infectious Disease Research, Seattle, Washington.
  • Kublin JG; Department of Laboratory Medicine, University of Washington, Seattle, Washington.
J Infect Dis ; 217(5): 693-702, 2018 02 14.
Article em En | MEDLINE | ID: mdl-29216395
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Triazóis / Malária Falciparum / Quimioprevenção / Antimaláricos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Triazóis / Malária Falciparum / Quimioprevenção / Antimaláricos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adolescent / Adult / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article